CHEMOCENTRYX INC's ticker is CCXI and the CUSIP is 16383L106. A total of 89 filers reported holding CHEMOCENTRYX INC in Q4 2016. The put-call ratio across all filers is 0.42 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $3,179,000 | +40.0% | 429,612 | +14.3% | 0.00% | – |
| Q3 2016 | $2,271,000 | +46.9% | 375,965 | +9.2% | 0.00% | – |
| Q2 2016 | $1,546,000 | +40.8% | 344,234 | -22.0% | 0.00% | – |
| Q1 2016 | $1,098,000 | -52.2% | 441,069 | +55.7% | 0.00% | – |
| Q4 2015 | $2,295,000 | +65.8% | 283,362 | +23.9% | 0.00% | – |
| Q3 2015 | $1,384,000 | -19.0% | 228,782 | +10.3% | 0.00% | – |
| Q2 2015 | $1,708,000 | -7.8% | 207,478 | -15.4% | 0.00% | – |
| Q1 2015 | $1,853,000 | +15.7% | 245,378 | +4.6% | 0.00% | – |
| Q4 2014 | $1,602,000 | +45.6% | 234,504 | -4.1% | 0.00% | – |
| Q3 2014 | $1,100,000 | -24.7% | 244,545 | -2.0% | 0.00% | – |
| Q2 2014 | $1,460,000 | -22.7% | 249,516 | -12.4% | 0.00% | – |
| Q1 2014 | $1,888,000 | +21.3% | 284,760 | +5.9% | 0.00% | – |
| Q4 2013 | $1,556,000 | -2.6% | 268,770 | -6.4% | 0.00% | – |
| Q3 2013 | $1,597,000 | -60.6% | 287,223 | +0.3% | 0.00% | -100.0% |
| Q2 2013 | $4,050,000 | – | 286,439 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tri Locum Partners LP | 296,327 | $7,429,000 | 2.90% |
| Integral Health Asset Management, LLC | 400,000 | $10,028,000 | 2.61% |
| Cormorant Asset Management, LP | 865,000 | $21,686,000 | 1.66% |
| HealthCor Management, L.P. | 956,740 | $23,985,000 | 1.60% |
| Sofinnova Investments, Inc. | 573,684 | $14,382,000 | 1.09% |
| Lisanti Capital Growth, LLC | 321,569 | $8,062,000 | 0.91% |
| Cahill Wealth Management, LLC | 44,913 | $1,125,000 | 0.84% |
| Perceptive Advisors | 1,655,079 | $41,493,000 | 0.83% |
| RA Capital Management | 1,155,964 | $28,980,000 | 0.63% |
| Avidity Partners Management LP | 1,175,000 | $29,457,000 | 0.61% |